Liu, Zhiyan
Xie, Qiufen
Zhang, Hanxu
Mu, Guangyan
Zhou, Shuang
Wang, Zining
Jiang, Jie
Xiang, Qian
Cui, Yimin
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (81973395)
National Science and Technology Major Projects for “Major New Drugs Innovation and Development” of China (2018ZX09201014, 2017ZX09101001, 2017ZX09304028)
National Natural Science Foundation of China (81872940)
Natural Science Foundation of Beijing Municipality (7171012)
Article History
Accepted: 12 April 2021
First Online: 18 June 2021
Declarations
:
: This study was supported by grants from the National Science and Technology Major Projects for “Major New Drugs Innovation and Development” of China (No. 2018ZX09201014, No. 2017ZX09101001 and No. 2017ZX09304028), National Natural Science Foundation of China (No. 81872940 and No. 81973395), and Natural Science Foundation of Beijing Municipality (No. 7171012).
: We declare no competing interests.
: The protocol was approved by an independent ethics committee and the Institutional Review Board of Peking University First Hospital and all participating research sub-central hospitals. The trial registration number is NCT03161496. All subjects were enrolled in this study after signing informed consent.
: The manuscript has been approved by all authors for publication. The work described is original research that has not been published previously; nor is it under consideration for publication elsewhere, in whole or in part.
: All data related to the study have been shown in the article, and other relevant data can be requested from the authors.
: Not applicable.
: (1) Conception and design: YC, QX, and JJ; (2) provision of study materials or patients: ZL, QX, QX, HZ, GM, and SZ; (3) collection and assembly of data: ZL, QX, QX, HZ, GM, and SZ; (4) data analysis and interpretation: ZL, QX, HZ, and QX; (5) manuscript writing and final approval of manuscript: all authors.